Arvid Carlsson
Arvid Carlsson (25 January 1923 – 29 June 2018) was a Swedish neuropharmacologist. He was best known for his work with the neurotransmitter dopamine and its effects on Parkinson's disease.
Arvid Carlsson | |
|---|---|
 | |
| Born | 25 January 1923 Uppsala, Sweden |
| Died | 29 June 2018 (aged 95) Gothenburg, Sweden |
| Nationality | Swedish |
| Alma mater | Lund University |
| Known for | Dopamine |
| Awards | Nobel Prize in Physiology or Medicine (2000) |
He won the Wolf Prize in Medicine in 1979. He was elected a member of the Academia Europaea in 1989.[1]
For his work on dopamine, Carlsson was awarded the Nobel Prize in Physiology or Medicine in 2000.[2] He won the award alongside Eric Kandel and Paul Greengard.
References
- ↑ Arvid CarlssonAcademia Europaea.
- ↑ Barondes, Samuel H.. Better Than Prozac (2003). New York: Oxford University Press. p. 21–22, 39–40. ISBN 0-19-515130-5.